HR 1199 · 118th Congress 2023–2025, ended

Facilitating Innovative Nuclear Diagnostics Act of 2023

Fact sheet

Latest action · May 16, 2024 Forwarded by Subcommittee to Full Committee by Voice Vote.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedFeb 27, 2023
  2. Passed HouseNot reached
  3. Passed SenateNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

Facilitating Innovative Nuclear Diagnostics Act of 2023

This bill establishes separate payment requirements for diagnostic radiopharmaceuticals under the Medicare prospective payment system for hospital outpatient department services. The bill's requirements apply to diagnostic radiopharmaceuticals that have an average daily cost of $500 or more in 2024 and as adjusted based on a specified fee schedule factor in each year thereafter.

Cosponsors 47

Members who signed on, in the order they did. Signatures ran from Feb 27, 2023 to Jul 10, 2024, with 15 there on the day it was introduced.

SeatCosponsorSigned on
D-NHAnn M. KusterOriginalFeb 27, 2023
D-NJBonnie Watson ColemanOriginalFeb 27, 2023
D-NHChris PappasOriginalFeb 27, 2023
R-NCGregory F. MurphyOriginalFeb 27, 2023
R-PAGuy ReschenthalerOriginalFeb 27, 2023
D-MAJake AuchinclossOriginalFeb 27, 2023
D-MAJames P. McGovernOriginalFeb 27, 2023
R-PAJohn JoyceOriginalFeb 27, 2023
R-INLarry BucshonOriginalFeb 27, 2023
D-DELisa Blunt RochesterOriginalFeb 27, 2023
D-MALori TrahanOriginalFeb 27, 2023
R-IAMariannette Miller-MeeksOriginalFeb 27, 2023
D-NYPaul TonkoOriginalFeb 27, 2023
D-CAScott H. PetersOriginalFeb 27, 2023
D-ALTerri A. SewellOriginalFeb 27, 2023

Actions 5

Everything that happened, newest first.

  1. May 16, 2024Forwarded by Subcommittee to Full Committee by Voice Vote.
  2. May 16, 2024Subcommittee Consideration and Mark-up Session Held
  3. Mar 10, 2023Referred to the Subcommittee on Health.
  4. Feb 27, 2023Introduced in House
  5. Feb 27, 2023Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
S 1544Facilitating Innovative Nuclear Diagnostics Act of 2023Identical billMay 10, 2023

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Feb 27, 2023Introduced in House

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov.